Bailey CG et al. Loss-of-function mutations in the glutamate transporter SLC1A1 cause human dicarboxylic aminoaciduria.J Clin Invest. 2011;121(1):446-53. PMID: 21123949.
Doan RN et al. Recessive gene disruptions in autism spectrum disorder.Nat Genet 2019; 51 (7): 1092–1098. PMID: 31209396.
Teijema HL et al. Dicarboxylic aminoaciduria: an inborn error of glutamate and aspartate transport with metabolic implications, in combination with a hyperprolinemia.Metabolism 1974; 23(2): 115-23. PMID: 4810805.
Swarna M et al. Dicarboxylic aminoaciduria associated with mental retardation. Hum Genet. 1989; 82(3):299-300. PMID: 2567279.
Szatmari P et al. Mapping autism risk loci using genetic linkage and chromosomal rearrangements.Nat Genet. 2007; 39(3): 319-328. PMID: 1732280.
Jacob S et al. Family-based association testing of glutamate transporter genes in autism.Psychiatr Genet. 2011; 21(4): 212-3. PMID 21085054.
Gadow KD et al. Glutamate transporter gene (SLC1A1) single nucleotide polymorphism (rs301430) and repetitive behaviors and anxiety in children with autism spectrum disorder.J Autism Dev Disord. 2010; 40(9): 1139-45. PMID 20155310.
Myles-Worsley M et al. Deletion at the SLC1A1 glutamate transporter gene co-segregates with schizophrenia and bipolar schizoaffective disorder in a 5-generation family.Am J Med Genet B Neuropsychiatr Genet. 2013;162B(2):87-95. PMID: 23341099.
Horiuchi Y et al. Association of SNPs linked to increased expression of SLC1A1 with schizophrenia.Am J Med Genet B Neuropsychiatr Genet. 2012;159B(1):30-7. PMID: 22095641.
Veenstra-VanderWeele J et al. Genomic organization of the SLC1A1/EAAC1 gene and mutation screening in early-onset obsessive-compulsive disorder. Molecular Psychiatry 2001;6:160-167. PMID: 11317217.
Hanna GL et al. Genome-wide linkage analysis of families with obsessive-compulsive disorder ascertained through pediatric probands. Am J Med Genet. 2002;114(5):541-52. PMID: 12116192.
Willour VL et al. Replication study supports evidence for linkage to 9p24 in obsessive-compulsive disorder.Am J Hum Genet. 2004;75(3):508-13. PMID: 15272418.
Arnold PD et al. Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder. Arch Gen Psychiatry. 2006;63(7):769-76. PMID: 16818866.
Dickel DE et al. Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder.JAMA Psychiatry 2006;63:778-785. PMID: 16818867.
Wendland JR et al. A haplotype containing quantitative trait loci for SLC1A1 gene expression and its association with obsessive-compulsive disorder.Arch Gen Psychiatry. 2009;66(4):408-16. PMID: 19349310.
Underhill SM et al. Amphetamine modulates excitatory neurotransmission through endocytosis of the glutamate transporter EAAT3 in dopamine neurons. Neuron. 2014;83(2):404-416. PMID: 25033183.
Zike ID et al. OCD candidate gene SLC1A1/EAAT3 impacts basal ganglia-mediated activity and stereotypic behavior. Proc Natl Acad Sci U S A. 2017;114(22):5719-5724. PMID: 28507136.
Delgado-Acevedo C et al. Behavioral and synaptic alterations relevant to obsessive-compulsive disorder in mice with increased EAAT3 expression. Neuropsychopharmacology. 2019;44(6):1163-1173. PMID: 30622300.
Chohan MO et al. Developmental impact of glutamate transporter overexpression on dopaminergic neuron activity and stereotypic behavior. Mol Psychiatry. 2022;27(3):1515-1526. PMID: 35058566.
Kopelman JM et al. Forebrain EAAT3 Overexpression Increases Susceptibility to Amphetamine-Induced Repetitive Behaviors. eNeuro. 2024;11(4):ENEURO.0090-24.2024. PMID: 38514191.
SLC1A1